title: Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia.
authors.affiliation: Department of Clinical Neurology and Stroke Unit, Multiple Sclerosis Center, Niguarda Ca' Granda Hospital, Piazza Ospedale Maggiore 3, 20162, Milan, Italy, lamantialore@gmail.com.
authors.forename: Loredana
authors.initials: L
authors.lastname: La Mantia
authors.forename: Valentina
authors.initials: V
authors.lastname: Prone
authors.forename: Maria Raffaella
authors.initials: MR
authors.lastname: Marazzi
authors.forename: Cristina
authors.initials: C
authors.lastname: Erminio
authors.forename: Alessandra
authors.initials: A
authors.lastname: Protti
mesh_terms: D000328:Adult; D005260:Female; D000068876:Fingolimod Hydrochloride; D005682:Gadolinium; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008231:Lymphopenia / Q000139:chemically induced*; D008279:Magnetic Resonance Imaging; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D005682:Gadolinium; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine
references.citation: Eur J Neurol. 2013 Aug;20(8):e109-10
references.pmid: 23829238
references.citation: Arch Neurol. 2012 Feb;69(2):262-4
references.pmid: 22332194
references.citation: Mult Scler. 2012 Nov;18(11):1636-9
references.pmid: 22829326
references.citation: J Neurol. 2013 Jan;260(1):327-9
references.pmid: 23161460
references.citation: J Neurol. 2013 Jun;260(6):1675-7
references.pmid: 23645219
references.citation: Semin Neurol. 2013 Feb;33(1):37-44
references.pmid: 23709211
references.citation: Neurology. 2013 Nov 12;81(20):1768-72
references.pmid: 24132373
references.citation: Neurology. 2012 Nov 6;79(19):2006-7
references.pmid: 23035074
references.citation: Mult Scler. 2013 Aug;19(9):1244-5
references.pmid: 23322501